How Do Antibody-Drug Conjugates (ADCs) Accurately Hit Their Targets? In-Depth Analysis of the Latest Analytical Techniques and Core Pharmacokinetic Modeling Strategies
On the battlefield of precise cancer treatment, Antibody-Drug Conjugates (ADCs) act like a “biological missile,” leveraging their precise targeting capabilities and powerful lethality to become a cornerstone of tumor therapy. However, the journey of this “missile” within the body is exceptionally complex, and accurately tracking it and predicting its behavior has become the key to … Read more